Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 6 | 2022 | 1036 | 1.170 |
Why?
|
| Insulin Resistance | 1 | 2022 | 373 | 0.710 |
Why?
|
| Spirituality | 2 | 2005 | 42 | 0.530 |
Why?
|
| Weight Gain | 2 | 2022 | 178 | 0.490 |
Why?
|
| Hospital Design and Construction | 1 | 2013 | 2 | 0.480 |
Why?
|
| Medical Order Entry Systems | 1 | 2012 | 46 | 0.460 |
Why?
|
| Medication Errors | 1 | 2012 | 109 | 0.440 |
Why?
|
| Norovirus | 1 | 2011 | 6 | 0.430 |
Why?
|
| Virus Shedding | 1 | 2011 | 19 | 0.430 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 204 | 0.420 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 42 | 0.410 |
Why?
|
| Diarrhea | 1 | 2011 | 66 | 0.410 |
Why?
|
| Patient Participation | 1 | 2013 | 185 | 0.410 |
Why?
|
| Neoplasms | 3 | 2005 | 1058 | 0.400 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 228 | 0.400 |
Why?
|
| Patient Care Team | 1 | 2012 | 275 | 0.390 |
Why?
|
| Protestantism | 2 | 2005 | 4 | 0.340 |
Why?
|
| Catholicism | 2 | 2005 | 4 | 0.330 |
Why?
|
| Therapeutic Touch | 1 | 2007 | 2 | 0.330 |
Why?
|
| Stereotaxic Techniques | 1 | 2007 | 19 | 0.330 |
Why?
|
| Pain Management | 1 | 2007 | 121 | 0.280 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2004 | 28 | 0.260 |
Why?
|
| Pastoral Care | 1 | 2004 | 1 | 0.260 |
Why?
|
| Hospices | 1 | 2004 | 21 | 0.260 |
Why?
|
| Carcinoma, Lobular | 1 | 2004 | 20 | 0.260 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 33 | 0.260 |
Why?
|
| Pain | 1 | 2007 | 309 | 0.260 |
Why?
|
| Hospice Care | 1 | 2004 | 37 | 0.260 |
Why?
|
| Carcinoma in Situ | 1 | 2004 | 33 | 0.260 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2004 | 42 | 0.260 |
Why?
|
| Nausea | 1 | 2003 | 35 | 0.240 |
Why?
|
| Vomiting | 1 | 2003 | 39 | 0.240 |
Why?
|
| Body Mass Index | 2 | 2022 | 852 | 0.230 |
Why?
|
| Female | 11 | 2022 | 26332 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 533 | 0.220 |
Why?
|
| Attitude to Health | 1 | 2004 | 291 | 0.220 |
Why?
|
| Length of Stay | 1 | 2004 | 627 | 0.210 |
Why?
|
| Regression Analysis | 3 | 2007 | 456 | 0.200 |
Why?
|
| Massachusetts | 3 | 2013 | 2021 | 0.200 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2012 | 75 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 591 | 0.180 |
Why?
|
| Humans | 13 | 2022 | 49658 | 0.170 |
Why?
|
| Insulin | 1 | 2022 | 658 | 0.170 |
Why?
|
| Middle Aged | 7 | 2011 | 13448 | 0.160 |
Why?
|
| Prospective Studies | 1 | 2022 | 2520 | 0.140 |
Why?
|
| Physician Incentive Plans | 1 | 2013 | 9 | 0.130 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 32 | 0.120 |
Why?
|
| Medical Oncology | 1 | 2013 | 40 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2007 | 835 | 0.120 |
Why?
|
| Anxiety | 2 | 2007 | 310 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2007 | 284 | 0.120 |
Why?
|
| Organizational Case Studies | 1 | 2013 | 42 | 0.120 |
Why?
|
| Sex Factors | 2 | 2005 | 850 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2011 | 99 | 0.100 |
Why?
|
| Adult | 5 | 2007 | 13328 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2012 | 422 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 224 | 0.100 |
Why?
|
| Adolescent | 3 | 2005 | 5322 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2013 | 471 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2007 | 2285 | 0.080 |
Why?
|
| Male | 5 | 2011 | 23131 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2007 | 109 | 0.080 |
Why?
|
| Aged | 4 | 2005 | 10869 | 0.080 |
Why?
|
| Risk Factors | 2 | 2007 | 4244 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2007 | 248 | 0.070 |
Why?
|
| Biopsy | 1 | 2007 | 326 | 0.070 |
Why?
|
| Love | 1 | 2005 | 1 | 0.070 |
Why?
|
| Breast | 1 | 2007 | 165 | 0.070 |
Why?
|
| Fear | 1 | 2005 | 51 | 0.070 |
Why?
|
| Morale | 1 | 2004 | 4 | 0.070 |
Why?
|
| Religion and Psychology | 1 | 2004 | 15 | 0.060 |
Why?
|
| Anger | 1 | 2004 | 27 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 104 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1041 | 0.060 |
Why?
|
| Emotions | 1 | 2005 | 181 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 186 | 0.060 |
Why?
|
| Feedback | 1 | 2003 | 82 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 372 | 0.060 |
Why?
|
| Health Services Research | 1 | 2004 | 252 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2004 | 627 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2005 | 364 | 0.060 |
Why?
|
| Mastectomy | 1 | 2022 | 50 | 0.060 |
Why?
|
| Mastectomy, Segmental | 1 | 2022 | 42 | 0.060 |
Why?
|
| Communication | 1 | 2005 | 442 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2004 | 463 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2007 | 3888 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 245 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2003 | 334 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 437 | 0.050 |
Why?
|
| Logistic Models | 1 | 2004 | 1159 | 0.050 |
Why?
|
| Mammography | 1 | 2022 | 241 | 0.050 |
Why?
|
| Obesity | 1 | 2007 | 1125 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2004 | 2064 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 3127 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2004 | 4517 | 0.030 |
Why?
|
| Reimbursement, Incentive | 1 | 2013 | 28 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2013 | 215 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2013 | 321 | 0.020 |
Why?
|
| Celecoxib | 1 | 2005 | 15 | 0.020 |
Why?
|
| Taxoids | 1 | 2005 | 26 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 153 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 177 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2005 | 59 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2005 | 115 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2005 | 301 | 0.020 |
Why?
|
| United States | 1 | 2013 | 6232 | 0.010 |
Why?
|